Front Cardiovasc Med . Case Report: Myocarditis Associated With COVID-19 mRNA Vaccination Following Myocarditis Associated With Campylobacter Jejuni

[tetano]

Front Cardiovasc Med


. 2022 Mar 18;9:837759.
doi: 10.3389/fcvm.2022.837759. eCollection 2022.
Case Report: Myocarditis Associated With COVID-19 mRNA Vaccination Following Myocarditis Associated With Campylobacter Jejuni




Nobuko Kojima[SUP] 1 [/SUP], Hayato Tada[SUP] 1 [/SUP], Hirofumi Okada[SUP] 1 [/SUP], Shohei Yoshida[SUP] 1 [/SUP], Kenji Sakata[SUP] 1 [/SUP], Soichiro Usui[SUP] 1 [/SUP], Hiroko Ikeda[SUP] 2 [/SUP], Masaki Okajima[SUP] 3 [/SUP], Masa-Aki Kawashiri[SUP] 1 [/SUP], Masayuki Takamura[SUP] 1 [/SUP]



Affiliations

• PMID: 35369323
• PMCID: PMC8971558
• DOI: 10.3389/fcvm.2022.837759

Abstract

We herein present our experience with a case involving a 17-year-old Japanese boy suffering from acute myocarditis after his second coronavirus disease-2019 (COVID-19) messenger RNA (mRNA) vaccine shot. The patients had a history of myocarditis associated with Campylobacter jejuni 3 years prior. This has been the first-ever documented case of myocarditis associated with COVID-19 mRNA vaccination in a patient with a history of myocarditis. We present a series of images and blood biomarkers for different types of myocarditis that developed in this single patient.

Keywords: COVID-19; cardiomyopathy; chest pain; left ventricle; myocarditis.